Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: The cost-effectiveness of controlling dengue in Indonesia using wMel Wolbachia released at scale: a modelling study

Fig. 2

Distribution of cumulative costs and savings over time in an accelerated (3 years, left panel) and sequenced (10 years, right panel) roll out in Yogyakarta City in 2018 USD. Uncertainty represents uncertainty in programme cost and intervention effectiveness beyond the 10-year post-release time horizon used in this analysis. All costs and benefits are in present-day value 2018 USD discounted at 3% per annum

Back to article page